Partners Demonstration Project of PrEP and ART

Phase 4 Completed 1013 enrolled University of Washington Bill and Melinda Gates Foundation · collab National Institute of Mental Health (NIMH) · collab United States Agency for International Development (USAID) · collab

NaSingle-groupOpen-labelPrevention

Summary

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners and to optimize targeted delivery and sustained use of these interventions.

Timeline

Start: 2012-11
Primary completion: 2016-06
Completion: 2016-06

Publications

Nakku-Joloba E, Pisarski EE, Wyatt MA, Muwonge TR, Asiimwe S, Celum CL, Baeten JM, Katabira ET, Ware NC. Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples. J Int AIDS Soc. 2019 Jan;22(1):e25225. doi: 10.1002/jia2.25225.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tenofovir disoproxil fumarate	Small molecule	—	Oral
Subject	emtricitabine	Other / unclassified	—	Oral

Partners Demonstration Project of PrEP and ART

Summary

Timeline

Publications

Drugs

Indications